Market Access & Business Strategy

Groundbreaking therapies promise cures but often come with price tags that overwhelm public budgets and private insurers alike. Hybrid insurance models—where public systems provide universal coverage and private insurers share responsibility for high-cost, innovative treatments—offer a path forward.

Is your healthcare growth strategy aligned with today’s evolving market? This blog explores how healthcare organizations can unlock hidden revenue streams through smarter business development and commercial advisory intelligence.

Health Technology Assessment (HTA) is a vital process that evaluates the clinical effectiveness, cost-efficiency, and broader impact of medical innovations—from drugs and devices to digital health tools. As healthcare systems face rising costs and increasing complexity, HTA provides the evidence-based foundation for smarter policy, better patient outcomes, and sustainable innovation. This blog explores why HTA matters now more than ever—and how it shapes the future of global

Expanding into new markets requires more than ambition—it demands a strategic, data-driven approach. This blog outlines a proven framework for designing effective market entry strategies, with a focus on healthcare. From defining objectives and assessing regulatory landscapes to choosing the right entry mode and building scalable operations, learn how to navigate complexity and unlock sustainable growth.

Blended finance is redefining how health systems are funded across Africa—unlocking private capital by strategically combining it with public and philanthropic resources. As traditional funding models fall short, this innovative approach enables scalable, sustainable investments that strengthen infrastructure, expand access, and drive long-term health outcomes. The future of African healthcare lies at the intersection of impact and investment.

The African Medicines Agency (AMA) is redefining regulatory access across Africa. By harmonizing standards and building regulatory capacity, AMA offers life sciences companies a faster, more efficient path to market—while advancing access to essential medicines continent-wide.

Tiered pricing is a critical tool for improving equitable access to medicines—by aligning prices with countries' ability to pay, it helps ensure life-saving treatments reach more people, without compromising innovation or market sustainability. This blog explores how tiered pricing works, why it matters, and what it takes to implement it effectively in global health systems.

A well-functioning health financing system is the backbone of Universal Health Coverage. This blog breaks down the core building blocks—revenue collection, risk pooling, strategic purchasing, and governance—and explains how their alignment drives equity, efficiency, and sustainability in health systems.

Navigating the diverse landscape of African markets requires a keen understanding of the prevalent market access barriers, ranging from complex regulatory frameworks and infrastructure deficits to cultural nuances and trade restrictions, and a strategic approach to effectively overcome these hurdles for sustainable growth.

Understanding the unique cultural nuances and adapting your business model accordingly is paramount to thriving when launching in emerging markets.

Successfully navigating the complexities of international markets requires a well-defined strategy that prioritizes cultural adaptation, localized operations, and a robust understanding of diverse consumer needs.

Navigating the diverse and often complex regulatory landscapes across African nations is a critical yet frequently underestimated factor for businesses seeking successful market expansion on the continent.

To thrive in Africa's diverse markets, businesses must strategically balance global brand consistency with nuanced localization that respects cultural, economic, and linguistic variations.